97353 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Novel apoptosis inducing factor and method of inducing apoptosis using the same
#302MATERIALS AND METHODS FOR PREPARING DIMERIC GROWTH FACTORS
#303Selection system
#304Capsid proteins and uses therefore
#305METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#306Immunoglobulin Directed Biocides
#307Virus coat protein/receptor chimeras and methods of use
#308Method for inducing protein aggregation using a polypeptide with an aggregation region
#309Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
#310Protein constructs designed for targeting and lysis of cells
#311T4 bacteriophage bound to a substrate
#312Antimicrobial Peptide Biocides
#313Innate Immune Receptor Directed Biocides
#314Fusion protein delivery system and uses thereof
#315Agents And Methods For Early Diagnosis And Monitoring Of Alzheimer's Disease And Other Neurological Disorders
#316PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS
#317Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#318PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#319ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#320PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#321Multimeric constructs
#322Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
#323Immunologically enhanced recombinant vaccines
#324GLP-1 FUSION PROTEINS
#325METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#326Methods for blocking TNF-alpha activity in mammals with trimeric soluble TNF receptors
#327Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
#328Materials and methods for preparing dimeric growth factors
#329Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin
#330Recombinant modified adenovirus fiber protein
#331Ferritin fusion proteins for use in vaccines and other applications
#332Stress proteins and uses therefor
#333Stress proteins and uses therefor
#334Insect viruses and their uses in protecting plants
#335Protein isolation and purification
#336Enrichment method for variant proteins with altered binding properties
#337Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#338Compositions and methods for phage display of polypeptides
#339Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#340Lambdoid bacteriophage vectors for expression of foreign proteins
#341Inducible inactivation of synaptic transmission
#342Insect viruses and their uses in protecting plants
#343Methods and compositions comprising bacteriophage nanoparticles
#344Virus coat protein/receptor chimeras and method of use
#345Nucleic acid encoding a self-assembling split-fluorescent protein system
#346Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
#347Multimerised HIV fusion inhibitors
#348Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
#349Self-assembling peptides incorporating modifications and methods of use thereof
#350Insect viruses and their uses in protecting plants
#351Phage display libraries of human Vfragments
#352Stress proteins and uses therefor
#353Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
#354Zinc finger protein derivatives and methods therefor
#355Targeted biocides
#356Fusion protein delivery system and uses thereof
#357SARS-CoV-2 fusion protein vaccine/regimen
#358Cargo carrying nanoparticles